GLP-1 receptor agonists: the cardiovascular benefits beyond glucose control.
Topic:
Risk Factors and Prevention
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Filip Krag Knop
Gentofte Hospital, University of Copenhagen, Copenhagen (Denmark)
4
presentations
0
follower
4 more presentations in this session
Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?
Speaker: Professor T. Luscher (London, GB)
Diabetes and cardiovascular disease: time for a multifactorial approach.
Speaker: Professor J. Deanfield (London, GB)
Translating GLP-1 trial outcomes to cardiology practice: which patients will benefit? .
Speaker: Professor L. Ryden (Stockholm, SE)
Discussion and summary - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?
Speaker: Professor T. Luscher (London, GB) Professor J. Deanfield (London, GB)
Access the full session
Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice? (EBAC Accredited)
Speakers:
Professor F. Krag Knop, Professor T. Luscher, Professor J. Deanfield, Professor L. Ryden, Professor T. Luscher...
About the event
ESC 365 is supported by
